A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma

Condition:   Asthma Interventions:   Drug: QVM149;   Drug: Salmeterol Xinafoate / Fluticasone Propionate;   Drug: Placebo to QVM149;   Drug: Placebo to Salmeterol Xinafoate / Fluticasone Propionate;   Drug: Run-In Medication;   Drug: Rescue Medication;   Device: Concept 1 Device;   Device: Girohaler Sponsor:   Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials